Company Encyclopedia
View More
name
MICROPORT EP
688351.SH
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and 3D navigation systems, as well as cryoablation solutions, such as ablation and diagnostic catheters for physicians. It also exports its products to France, Italy, Bulgaria, Brazil, Thailand, and internationally.
893.67 B
688351.SHMarket value -Rank by Market Cap -/-

Financial Score

29/12/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking9/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.97%C
    • Profit Margin11.39%B
    • Gross Margin58.65%B
  • Growth ScoreB
    • Revenue YoY19.46%B
    • Net Profit YoY45.60%B
    • Total Assets YoY5.06%C
    • Net Assets YoY3.50%C
  • Cash ScoreB
    • Cash Flow Margin877.66%B
    • OCF YoY19.46%B
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreA
    • Gearing Ratio8.73%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    MICROPORT EP: Net profit in the first half of the year was 32.6681 million yuan, a year-on-year increase of 92.02%

    On the evening of August 26, MICROPORT EP disclosed its semi-annual report for 2025, achieving operating revenue of 224 million yuan in the first half of the year, a year-on-year increase of 12.8%; net profit attributable to the parent company was 32.6681 million yuan, a year-on-year increase of 92.02%; basic earnings per share were 0.0694 yuan. The changes in operating data were mainly due to the growth in sales scale during the reporting period and the profit growth brought about by cost reduction and efficiency improvement

    Zhitong·
    SH
    688351
    +0.17%
    Zhitong·
    SH
    688351
    +0.17%

    MICROPORT EP expects a half-year net profit attributable to the parent company of 30 million to 35 million yuan, an increase of 76.34% to 105.73% year-on-year

    MICROPORT EP expects the net profit attributable to the parent company for the first half of 2025 to be between 30 million and 35 million yuan, an increase of 76.34% to 105.73% year-on-year. The company focuses on the field of cardiac electrophysiology and actively expands the atrial fibrillation treatment market, relying on multiple technological advantages. Thanks to the successful promotion of new products overseas, the company's overseas market sales performance has been outstanding, driving significant growth in overall sales and net profit

    Zhitong·
    SH
    688351
    +0.17%
    Zhitong·
    SH
    688351
    +0.17%

    MICROPORT EP: IceMagic ® balloon-type cryoablation catheter has obtained EU MDR certification

    MICROPORT EP announced that its IceMagic® balloon cryoablation catheter has obtained EU Medical Device Regulation (MDR) certification. This marks the official entry of the company's cryo series products into the international market, helping to enhance brand awareness and expand overseas markets

    Zhitong·
    SH
    688351
    +0.17%
    Zhitong·
    SH
    688351
    +0.17%

    MICROPORT EP: Net profit in the first quarter increased by 328.63% year-on-year

    MICROPORT EP announced that in the first quarter of 2025, operating revenue was 104 million yuan, a year-on-year increase of 16.77%; net profit attributable to shareholders of the listed company was 17.8705 million yuan, a year-on-year increase of 328.63%. This was mainly due to the growth in the company's sales scale during the reporting period and the profit growth brought about by the implementation of cost reduction and efficiency enhancement measures

    Zhitong·
    SH
    688351
    +0.17%
    Zhitong·
    SH
    688351
    +0.17%

    MICROPORT EP released its 2024 annual performance, with a net profit attributable to the parent company of 52.07 million yuan, a year-on-year increase of 815.36%

    MICROPORT EP released its 2024 annual performance, achieving revenue of 413 million yuan during the reporting period, a year-on-year increase of 25.51%; net profit attributable to the parent company was 52.07 million yuan, a year-on-year increase of 815.36%; net profit excluding non-recurring gains and losses was 5.08 million yuan, turning from loss to profit year-on-year; basic earnings per share were 0.1106 yuan. The growth in performance was mainly due to the expansion of business scale and an increase in product sales

    Zhitong·
    SH
    688351
    +0.17%
    Zhitong·
    SH
    688351
    +0.17%
    © 2025 Longbridge｜Disclaimer